$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,731 | 128,489 | 69,587 | |
Jan 26 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 77.68 | 11,109 | 862,947 | 3,521 | 14.6 K to 3.5 K (-75.93 %) |
Jan 26 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,777 | 50,875 | 14,630 | 11.9 K to 14.6 K (+23.43 %) |
Jan 26 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 601 | 9,989 | 11,853 | 11.3 K to 11.9 K (+5.34 %) |
Jan 26 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,731 | 128,489 | 11,252 | 3.5 K to 11.3 K (+219.57 %) |
Jan 22 2015 | INCY | INCYTE CORP | Clancy Paul J | Director | Option Exercise | A | 77.40 | 5,000 | 387,000 | 5,000 | |
Jan 22 2015 | INCY | INCYTE CORP | Clancy Paul J | Director | Option Exercise | A | 77.40 | 25,000 | 1,935,000 | 25,000 | |
Jan 22 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 77.40 | 5,000 | 387,000 | 5,000 | |
Jan 22 2015 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 77.40 | 25,000 | 1,935,000 | 25,000 | |
Jan 20 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | M | 3.11 | 17,500 | 54,425 | 51,469 | |
Jan 20 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Sell | S | 74.17 | 17,500 | 1,297,975 | 21,083 | 38.6 K to 21.1 K (-45.36 %) |
Jan 20 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Buy | M | 3.11 | 17,500 | 54,425 | 38,583 | 21.1 K to 38.6 K (+83.01 %) |
Jan 20 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 12,000 | 176,640 | 8,317 | |
Jan 20 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 73.07 | 12,000 | 876,840 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Jan 20 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 12,000 | 176,640 | 30,205 | 18.2 K to 30.2 K (+65.92 %) |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 14.00 | 4,167 | 58,338 | 0 | |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 17.79 | 11,308 | 201,169 | 11,308 | |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | M | 17.79 | 151 | 2,686 | 2,234 | |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Sell | S | 75.00 | 15,626 | 1,171,950 | 3,355 | 19 K to 3.4 K (-82.32 %) |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 14.00 | 4,167 | 58,338 | 18,981 | 14.8 K to 19 K (+28.13 %) |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 17.79 | 11,308 | 201,169 | 14,814 | 3.5 K to 14.8 K (+322.53 %) |
Jan 12 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Buy | M | 17.79 | 151 | 2,686 | 3,506 | 3.4 K to 3.5 K (+4.50 %) |
Jan 09 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 73.21 | 1,365 | 99,932 | 1,365 | |
Jan 09 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 73.21 | 18,635 | 1,364,268 | 18,635 | |
Jan 09 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 73.21 | 1,559 | 114,134 | 1,559 | |
Jan 09 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Option Exercise | A | 73.21 | 19,986 | 1,463,175 | 19,986 | |
Jan 09 2015 | INCY | INCYTE CORP | Wenqing Yao | EVP, Discovery Medi ... | Grant | A | 0.00 | 3,022 | 0 | 39,316 | 36.3 K to 39.3 K (+8.33 %) |
Jan 09 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 73.21 | 1,356 | 99,273 | 1,356 | |
Jan 09 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 73.21 | 20,189 | 1,478,037 | 20,189 | |
Jan 09 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Grant | A | 0.00 | 3,022 | 0 | 21,083 | 18.1 K to 21.1 K (+16.73 %) |
Jan 09 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 73.21 | 1,356 | 99,273 | 1,356 | |
Jan 09 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Option Exercise | A | 73.21 | 20,189 | 1,478,037 | 20,189 | |
Jan 09 2015 | INCY | INCYTE CORP | Siegel Eric H. | EVP, General Counse ... | Grant | A | 0.00 | 3,022 | 0 | 3,355 | 333 to 3.4 K (+907.51 %) |
Jan 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 73.21 | 1,085 | 79,433 | 1,085 | |
Jan 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 73.21 | 20,460 | 1,497,877 | 20,460 | |
Jan 09 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Grant | A | 0.00 | 3,022 | 0 | 21,227 | 18.2 K to 21.2 K (+16.60 %) |
Jan 09 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 73.21 | 1,365 | 99,932 | 1,365 | |
Jan 09 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 73.21 | 28,635 | 2,096,368 | 28,635 | |
Jan 09 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 73.21 | 1,423 | 104,178 | 1,423 | |
Jan 09 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | A | 73.21 | 20,122 | 1,473,132 | 20,122 | |
Jan 09 2015 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Grant | A | 0.00 | 3,022 | 0 | 44,562 | 41.5 K to 44.6 K (+7.27 %) |
Jan 09 2015 | INCY | INCYTE CORP | Hoppenot Herve | Chief Executive Off ... | Option Exercise | A | 73.21 | 1,365 | 99,932 | 1,365 | |
Jan 09 2015 | INCY | INCYTE CORP | Hoppenot Herve | Chief Executive Off ... | Option Exercise | A | 73.21 | 88,406 | 6,472,203 | 88,406 | |
Jan 09 2015 | INCY | INCYTE CORP | Hoppenot Herve | Chief Executive Off ... | Grant | A | 0.00 | 12,592 | 0 | 412,592 | 400 K to 412.6 K (+3.15 %) |
Jan 09 2015 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 73.21 | 599 | 43,853 | 599 | |
Jan 09 2015 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 73.21 | 20,946 | 1,533,457 | 20,946 | |
Jan 09 2015 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Grant | A | 0.00 | 3,022 | 0 | 10,850 | 7.8 K to 10.9 K (+38.61 %) |
Jan 09 2015 | INCY | INCYTE CORP | Flannelly Barry P | EVP, Business Devel ... | Option Exercise | A | 73.21 | 599 | 43,853 | 599 | |
Jan 09 2015 | INCY | INCYTE CORP | Flannelly Barry P | EVP, Business Devel ... | Option Exercise | A | 73.21 | 20,946 | 1,533,457 | 20,946 | |
Jan 09 2015 | INCY | INCYTE CORP | Flannelly Barry P | EVP, Business Devel ... | Grant | A | 0.00 | 3,022 | 0 | 3,022 | 0 to 3 K |
Jan 09 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | A | 73.21 | 1,099 | 80,458 | 1,099 | |
Jan 09 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | A | 73.21 | 20,446 | 1,496,852 | 20,446 | |
Jan 09 2015 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Grant | A | 0.00 | 3,022 | 0 | 3,521 | 499 to 3.5 K (+605.61 %) |
Jan 09 2015 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 73.21 | 1,365 | 99,932 | 1,365 | ||
Jan 09 2015 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 73.21 | 4,405 | 322,490 | 4,405 | ||
Jan 09 2015 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 73.21 | 1,396 | 102,201 | 1,396 | ||
Jan 09 2015 | INCY | INCYTE CORP | Chardonnet Laurent | Option Exercise | A | 73.21 | 6,818 | 499,146 | 6,818 | ||
Jan 09 2015 | INCY | INCYTE CORP | Chardonnet Laurent | Grant | A | 0.00 | 1,152 | 0 | 2,905 | 1.8 K to 2.9 K (+65.72 %) | |
Jan 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 18.32 | 25,000 | 458,000 | 116,782 | |
Jan 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 71.84 | 25,000 | 1,796,000 | 18,205 | 43.2 K to 18.2 K (-57.86 %) |
Jan 08 2015 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 18.32 | 25,000 | 458,000 | 43,205 | 18.2 K to 43.2 K (+137.32 %) |
Jan 07 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | M | 3.11 | 17,500 | 54,425 | 68,969 | |
Jan 07 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Sell | S | 73.90 | 17,500 | 1,293,250 | 18,061 | 35.6 K to 18.1 K (-49.21 %) |
Jan 07 2015 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Buy | M | 3.11 | 17,500 | 54,425 | 35,561 | 18.1 K to 35.6 K (+96.89 %) |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 502 | 8,343 | 6,016 | |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,833 | 130,184 | 77,318 | |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 33,432 | |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 74.43 | 11,113 | 827,141 | 0 | 11.1 K to 0 (-100.00 %) |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 502 | 8,343 | 11,113 | 10.6 K to 11.1 K (+4.73 %) |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,833 | 130,184 | 10,611 | 2.8 K to 10.6 K (+281.97 %) |
Dec 29 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 2,778 | 0 to 2.8 K |
Dec 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 12,000 | 176,640 | 20,317 | |
Dec 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 72.36 | 12,000 | 868,320 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Dec 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 12,000 | 176,640 | 30,205 | 18.2 K to 30.2 K (+65.92 %) |
Dec 03 2014 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Sell | S | 74.87 | 47,800 | 3,578,786 | 105,000 | 152.8 K to 105 K (-31.28 %) |
Dec 03 2014 | INCY | INCYTE CORP | DE SCHUTTER RICHARD U | Director | Sell | S | 75.26 | 2,200 | 165,572 | 152,800 | 155 K to 152.8 K (-1.42 %) |
Dec 03 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 9.41 | 6,494 | 61,109 | 0 | |
Dec 03 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 9.41 | 6,494 | 61,109 | 41,386 | 34.9 K to 41.4 K (+18.61 %) |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 501 | 8,327 | 6,518 | |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,832 | 130,168 | 85,151 | |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 36,210 | |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 74.08 | 11,111 | 823,103 | 0 | 11.1 K to 0 (-100.00 %) |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 501 | 8,327 | 11,111 | 10.6 K to 11.1 K (+4.72 %) |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,832 | 130,168 | 10,610 | 2.8 K to 10.6 K (+281.93 %) |
Nov 26 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 2,778 | 0 to 2.8 K |
Nov 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 12,000 | 176,640 | 32,317 | |
Nov 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 69.97 | 12,000 | 839,640 | 18,205 | 30.2 K to 18.2 K (-39.73 %) |
Nov 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 12,000 | 176,640 | 30,205 | 18.2 K to 30.2 K (+65.92 %) |
Nov 14 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 3.11 | 7,225 | 22,470 | 0 | |
Nov 14 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 5.46 | 2,900 | 15,834 | 0 | |
Nov 14 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Option Exercise | M | 9.41 | 7,835 | 73,727 | 6,494 | |
Nov 14 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 3.11 | 7,225 | 22,470 | 34,892 | 27.7 K to 34.9 K (+26.11 %) |
Nov 14 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 5.46 | 2,900 | 15,834 | 27,667 | 24.8 K to 27.7 K (+11.71 %) |
Nov 14 2014 | INCY | INCYTE CORP | Huber Reid M | EVP, Chief Scientif ... | Buy | M | 9.41 | 7,835 | 73,727 | 24,767 | 16.9 K to 24.8 K (+46.27 %) |
Nov 07 2014 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 13.34 | 29,166 | 389,074 | 0 | |
Nov 07 2014 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Option Exercise | M | 9.41 | 156,487 | 1,472,543 | 0 | |
Nov 07 2014 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Sell | S | 67.87 | 185,653 | 12,600,269 | 417,518 | 603.2 K to 417.5 K (-30.78 %) |
Nov 07 2014 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 13.34 | 29,166 | 389,074 | 603,171 | 574 K to 603.2 K (+5.08 %) |
Nov 07 2014 | INCY | INCYTE CORP | FRIEDMAN PAUL A | Director | Buy | M | 9.41 | 156,487 | 1,472,543 | 574,005 | 417.5 K to 574 K (+37.48 %) |
Nov 04 2014 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 67.06 | 50,903 | 3,413,555 | 50,903 | |
Nov 04 2014 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Option Exercise | A | 67.06 | 4,473 | 299,959 | 4,473 | |
Nov 04 2014 | INCY | INCYTE CORP | GRYSKA DAVID W | Executive Vice Pres ... | Grant | A | 0.00 | 7,828 | 0 | 7,828 | 0 to 7.8 K |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 501 | 8,327 | 7,019 | |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,832 | 130,168 | 92,983 | |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 38,988 | |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 53.49 | 11,111 | 594,327 | 0 | 11.1 K to 0 (-100.00 %) |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 501 | 8,327 | 11,111 | 10.6 K to 11.1 K (+4.72 %) |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,832 | 130,168 | 10,610 | 2.8 K to 10.6 K (+281.93 %) |
Oct 24 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 2,778 | 0 to 2.8 K |
Oct 24 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 3.11 | 13,904 | 43,241 | 0 | |
Oct 24 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 3.11 | 13,904 | 43,241 | 18,205 | 4.3 K to 18.2 K (+323.27 %) |
Oct 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 44,317 | |
Oct 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 49.03 | 8,000 | 392,240 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
Oct 20 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 502 | 8,343 | 7,520 | |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,832 | 130,168 | 100,815 | |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,777 | 50,875 | 41,766 | |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 47.65 | 11,111 | 529,439 | 0 | 11.1 K to 0 (-100.00 %) |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 502 | 8,343 | 11,111 | 10.6 K to 11.1 K (+4.73 %) |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,832 | 130,168 | 10,609 | 2.8 K to 10.6 K (+282.03 %) |
Sep 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,777 | 50,875 | 2,777 | 0 to 2.8 K |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 501 | 8,327 | 8,022 | |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,832 | 130,168 | 108,647 | |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 44,543 | |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 51.96 | 11,111 | 577,328 | 0 | 11.1 K to 0 (-100.00 %) |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 501 | 8,327 | 11,111 | 10.6 K to 11.1 K (+4.72 %) |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,832 | 130,168 | 10,610 | 2.8 K to 10.6 K (+281.93 %) |
Aug 27 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 2,778 | 0 to 2.8 K |
Sep 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 52,317 | |
Sep 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 47.58 | 8,000 | 380,640 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
Sep 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
Aug 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 60,317 | |
Aug 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 51.97 | 8,000 | 415,760 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
Aug 19 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
Aug 13 2014 | INCY | INCYTE CORP | Flannelly Barry P | See Remarks | Option Exercise | A | 48.44 | 42,218 | 2,045,040 | 42,218 | |
Aug 13 2014 | INCY | INCYTE CORP | Flannelly Barry P | See Remarks | Option Exercise | A | 48.44 | 6,192 | 299,940 | 6,192 | |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 501 | 8,327 | 8,523 | |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,832 | 130,168 | 116,479 | |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,778 | 50,893 | 47,231 | |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 48.54 | 11,111 | 539,328 | 0 | 11.1 K to 0 (-100.00 %) |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 501 | 8,327 | 11,111 | 10.6 K to 11.1 K (+4.72 %) |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 16.62 | 7,832 | 130,168 | 10,610 | 2.8 K to 10.6 K (+281.93 %) |
Jul 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Buy | M | 18.32 | 2,778 | 50,893 | 2,778 | 0 to 2.8 K |
Jul 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 14.72 | 8,000 | 117,760 | 68,317 | |
Jul 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 48.15 | 8,000 | 385,200 | 4,301 | 12.3 K to 4.3 K (-65.04 %) |
Jul 18 2014 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 14.72 | 8,000 | 117,760 | 12,301 | 4.3 K to 12.3 K (+186.00 %) |
Jun 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 502 | 8,343 | 9,024 | |
Jun 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 16.62 | 7,832 | 130,168 | 124,311 | |
Jun 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Option Exercise | M | 18.32 | 2,777 | 50,875 | 50,099 | |
Jun 25 2014 | INCY | INCYTE CORP | Daly James M | EVP, Chief Commerci ... | Sell | S | 55.92 | 8,334 | 466,037 | 0 | 8.3 K to 0 (-100.00 %) |